Gilead licenses HIV prevention drug to generic manufacturers
The drug, which has been hailed as a game-changer in the fight against HIV, will be available at a lower cost.
Gilead licenses HIV prevention drug to generic manufacturers Read More »
The drug, which has been hailed as a game-changer in the fight against HIV, will be available at a lower cost.
Gilead licenses HIV prevention drug to generic manufacturers Read More »
World Health Organization warns that limited testing capacity in the Democratic Republic of the Congo is fueling the spread of mpox.
Limited testing hampers mpox response in DRC Read More »
The mpox outbreak has been particularly severe in the Democratic Republic of Congo.
Africa CDC raises $600 million to fight mpox outbreak Read More »
The Democratic Republic of Congo has received 50,000 additional mpox vaccine doses from the United States to help combat the ongoing epidemic.
DRC receives 50,000 more mpox vaccines from the US Read More »
Guinea has confirmed its first case of mpox, joining other countries in the region experiencing outbreaks of the virus.
West Africa faces new health threat as Guinea reports mpox case Read More »
Conflicts, climate change, and inadequate sanitation contribute to the crisis.
Cholera cases surge 13 pct globally, deaths rise 71 pct — WHO Read More »
The companies will collaborate on localizing the drug’s production in Egypt.
Eli Lilly licenses Olumiant production to Egypt’s Eva Pharma Read More »
Aspen Pharmacare is exploring the production of mpox vaccines to address the ongoing outbreak in Africa.
African drugmaker in talks for mpox vaccine production Read More »
Africa is desperately seeking funds to combat the surging mpox outbreak, with less than 10% of the estimated $245 million needed secured.
Africa faces funding shortage to combat mpox outbreak Read More »
Vaccine inequity remains a major issue as Congo awaits its first shipment of mpox vaccines.
Congo’s fight against mpox delayed by vaccine supply issues Read More »